Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

FDA Warns Against Use of Pfizer's Revatio in Children

Posted Aug 30 2012 5:42pm
U.S. health regulators recommended against use of Pfizer Inc's pulmonary arterial hypertension (PAH) drug Revatio in children up to 17 years of age, saying it had a higher risk of death when taken in a high dose.
Source: Reuters Health
Related MedlinePlus Pages: Medicines and Children , Pulmonary Hypertension
Post a comment
Write a comment:

Related Searches